COMPANY NEWS
March 3, 2023
Ballantyne is the co-founder and former chief scientific officer of Aldevron, a leading manufacturer of plasmids and other biologicals
November 5, 2022
CureLab Oncology and CureLab Veterinary are looking for interns to work with our FDA/USDA team on regulatory activities
September 10, 2022
While the disease has progressed in all patients receiving standard of care, it did not progress in 40% of the patients receiving standard chemotherapy together with the experimental drug, Elenagen — and for half of the patients in the group, Elenagen has increased the time to disease progression by more than 2.5 times
May 3, 2022
Patent registration in South Korea opens door to commercial agreements in an enormous market with high economic potential for CureLab
April 22, 2022
The university is also renewing its agreement with CureLab Oncology to support its phase II clinical trials